Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice

Endocrinology

Volumn 136, Issue 2, 1995, Pages 609-613

  Jafarjan Tehrani, Mehrnaz ^a   Amrani, Abdelaziz ^c   Homo Delaftche, Françoise ^c   Marquette, Chfustel ^a,b   Dardenne, Mireille ^c   Haour, France ^a  

^a Pkarmacologie Neuro Immune Endocrinienne ^*  (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SPLEEN;

ANIMAL; AUTORADIOGRAPHY; BINDING, COMPETITIVE; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; INTERLEUKIN-1; ISLETS OF LANGERHANS; MICE; MICE, INBRED C3H; MICE, INBRED NOD; RECEPTORS, INTERLEUKIN-1; SPLEEN; SUPPORT, NON-U.S. GOV'T;

EID: 0028942160     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.136.2.7835294     Document Type: Article

References (42)

1. Thibault V, Terlain B, Ekindjian OG 1993 Interleukin-1 and glucose homeostasis regulation. Pathol Biol 41:178-186
2. Vogel SN, Henricson BE, Neta R 1991 Role of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia. Infect Immun 59:2494-2498
3. Del Rey A, Besedovsky H 1989 Antidiabetic effects of interleukin 1. Proc Natl Acad Sci USA 86:5943-5947
4. Del Rey A, Besedovsky H 1992 Metabolic and neuroendocrine effects of pro-inflammatory cytokines. Eur J Clin Invest 22:10-15
5. Jhala U, Baly DL 1994 Effect of chronic IL-1 β infusion on glucose homeostasis and pancreatic insulin secretion. Life Sci 54:413-422
6. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N 1991 Biochemical and molecular actions of interleukin-1 on pancreatic 0-cells. Autoimmunity 10:241-253
7. Argiles JM, Lopez-Soriano J, Ortiz A, Pou JM, Lopez-Soriano F J 1992 Interleukin-1 and 0-cell function: more than one second mes-sager? Endocr Rev 13:515-524
8. Purello F, Buscema M 1993 Effects of interleukin-10 on insulin secretion by pancreatic beta-cells. Diabetes Nutr Metab 6:295-304
9. Spinas GA, Mandrup-Poulsen T, Moolvig J, Back L, Bendtzen K, Dinarello CA, Nerup J 1986 Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenh) 113:551-558
10. Wogensen LD, Kolb-Bachofen V, Christensen P, Dinarello CA, Mandrup-Poulsen T, Martin S, Nerup J 1990 Functional and morphological effects of interleukin-10 on the perfused rat pancreas. Diabetologia 33:15-23
11. Eizirik DL, Welsh N, Hellerstrom C 1993 Predominance of stimulatory effects of interleukin-10 on isolated human pancreatic islets. J Clin Endocrinol Metab 76:399-403
12. Zumsteg U, Reimers JI, Pociot F, Moorch L, Helqvist S, Brendel M, Alejandro R, Mandrup-Poulsen T, Dinarello CA, Nerup J 1993 Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats. Diabetologia 36:759-766
13. Sandler S, Andersson A, Hellerstrom C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121:1424-1431
14. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH 1986 Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29:63-67
15. Pukel C, Baquerizo H, Rabinovitch A 1988 Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interfer-on-y, tumor necrosis factor, lymphotoxin and interleukin 1. Diabetes 37:133-136
16. Ling Z, In't veld PA, Pipeleers DG 1993 Interaction of interleukin-1 with islet 0-cells: distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes 42:56-65
17. Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz RJ 1990 Insulin-secreting 0-cells possess specific receptors for interleukin-10. FEBS Lett 261:97-100
18. Eizirik DL, Bjorklund A, Welsh N 1993 Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett 317:62-66
19. Deyerle KL, Sims JE, Dower SK, Bothwell MA1992 Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 149:1657-1665
20. Eizirik DL, Tracey DE, Bendtzen K, Sandler S 1992 Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic 0-cells. Autoimmunity 12:127-133
21. Dayer-Metroz MD, Wollheim CB, Seckinger P, Dayer JM 1989 A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmunity 2:163-171
22. Haour F, Ban E, Milon G, Baran D, Fillion G 1990 Brain interleukin 1 receptors: characterization and modulation after lipopolysaccha-ride injection. Prog NeuroEndocrinlmmunol 3:196-204
23. Ban E, Milon G, Prudhomme N, Fillion G, Haour F 1991 Receptors for interleukin-1 (a and 0) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43:21-30
24. Lampeter EF, Signore A, Gale EAM, Pozzilli P 1989 Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type I (insulin-dependent) diabetes mellitus. Diabetologia 32:703-708
25. Pozzilli P, Signore A, Williams AJK, Beales PE 1993 NOD mouse colonies around the world recent facts and figures. Immunol Today 14:193-196
26. Comall RJ, Prins J-B, Todd JA, Pressey A, DeLarato NH, Wicker LS, Peterson LB 1991 Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg genes on chromosome 1. Nature 353:262-264
27. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M 1991 Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 129:1382-1390
28. Dower SK, Call SM, Gillis S, Urdal DL 1986 Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci USA 83:1060-1064
29. Takao T, Culp SG, Newton RC, De Souza EB 1992 Type I interleukin-1 receptors in the mouse brain-endocrine-immune axis labelled with [Ijrecombinant human interleukin-1 receptor antagonist. J Neuroimmunol 41:51-60
30. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA 1994 Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and 0-cell destruction in NOD mice. Diabetes 43:667-675
31. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, McDaniel ML 1992 Interleukin 10 induces the formation of nitric oxide by 0-cells purified from rodent islets of Langerhans. J Clin Invest 90:2384-2391
32. Issekutz TB1992 Lymphocyte homing to sites of inflammation. Curr Opin Immunol 4:287-293
33. Prieto J, Kaaya EE, Juntti-Berggren L, Berggren PO, Sandler S, Biberfeld P, Patarroyo M 1992 Induction of intercellular adhesion molecule-1 (CD54) on isolated mouse pancreatic 0-cells by inflammatory cytokines. Clin Immunol Immunopathol 65:247-253
34. Green IC, Delaney CA, Cunningham JM, Karmiris V, Southern C 1993 Interleukin-10 effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans, arginine-dependence and relationship to insulin secretion. Diabetologia 36:9-16
35. Buschard K 1991 The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Autoimmunity 10: 65-69
36. Atkinson MA, Maclaren NK 1993 Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92:1608-1616
37. Mehta V, Hao W, Brooks-Worrell BM, Palmer JP 1993 The functional state of the 0 cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res 12:255-259
38. Yamada K, Takane N, Otabe S, Inada C, Inoue M, Nonaka K 1993 Pancreatic 0-cell-selective production of tumor necrosis factor-a induced by interleukin-1. Diabetes 42:1026-1031
39. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea 1990 Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-a and interleukin 1. Proc Natl Acad Sci USA 87:968-972
40. Rabinovich A1994 Perspectives in diabetes. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43:613-621
41. Durant S, Coulaud J, Amrani A, El Hasnaoui A, Dardenne M, Homo-Delarche F 1993 Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non-obese diabetic (NOD) mouse. J Autoimmunity 6:735-751
42. Homo-Delarche F, Amrani A, Jafarian Tehrani M, Pleau J M, Mormede P, Dardenne M, Haour F 1994 Interleukin 1 (IL-1) receptors are present and functional in the nonobese diabetic (NOD) mouse at the prediabetic stage. J Cell Biol 18A:146